Svetlana Mojsov

Svetlana Mojsov, born on December eighth, nineteen forty-seven, is a distinguished biochemist who has made significant contributions to the field of peptide synthesis. As a research associate professor at Rockefeller University, she has dedicated her career to advancing our understanding of complex biochemical processes.

Her groundbreaking research led to the discovery of glucagon-like peptide-1 (GLP-1), a pivotal hormone that plays a crucial role in glucose metabolism and insulin secretion. This discovery has not only enhanced scientific knowledge but has also paved the way for innovative therapeutic agents.

Transforming her findings into practical applications, Novo Nordisk has developed treatments for diabetes and obesity based on her work. Svetlana's contributions continue to impact the lives of many, showcasing the vital intersection of research and real-world health solutions.